My Crash Course Lecture on the history (and present) of humanity's deadliest infectious disease: youtu.be/7D-gxaie6UI?si… Thanks to everyone who made this video possible.

NIAID releases its 2024 Strategic Plan for Tuberculosis Research, an update to the first plan issued in 2018 niaid.nih.gov/news-events/wo…

Do you have a question about next-generation sequencing for drug-resistant TB? The Global Laboratory Initiative, a Stop TB Partnership working group, might have your answer! Read their recently released FAQs here: stoptb.org/global-laborat… #YesWeCanEndTB #HealthForAll

Dr. Ethel Weld presents encouraging findings from the "Dolphin-Too" trial, confirming the safety and efficacy of combining DTG-based ARVs with TB prevention drugs 3HP. Find out more: the-star.co.ke/health/2024-03…

The recording for the TBnet webinar "Targeted next generation sequencing for detection of drug-resistant tuberculosis" is now available! tbnet.eu/post/tbnet-28-…

New webinar on implementing targeted next-gen sequencing #tNGS for DR-TB detection 17 Apr 12.00 (GMT+2) FIND Stop TB Partnership Unitaid USAID sign up now! us06web.zoom.us/webinar/regist… #SeqnTreat Madhu Pai, MD, PhD World Health Organization (WHO) The Union MSF_TB CDC TB Treatment Action Group (TAG)

A new study by NIHR Oxford Biomedical Research Centre, Jenner Institute, Immunology and Immunotherapy, and Respiratory Medicine Research Unit has established an innovative way to test #tuberculosis vaccines using controlled aerosol lung infections. This could help develop better #TB vaccines 💉🦠🫁 Read more 👉 ndm.ox.ac.uk/news/aerosol-h…

SAVE THE DATE: TAG is hosting a webinar on May 15 on TB diagnostics research and development. Join us for info and discussion on new tools in the pipeline, and key considerations for implementation and advocacy. Get details and register: treatmentactiongroup.org/webinar/tb-dia…

📣 New article now in Frontiers #Tuberculosis 📣 We held a #workshop to ask experts from countries with a high TB burden what #epi, #impact, #feasibility and #acceptability data they would need to decide whether to introduce new TB #vaccines 🌏🧮 frontiersin.org/articles/10.33…

Hoping lots of you can join us UCL-TB for another webinar in our TB medicines access series. We will be discussing access to rifapentine on 12th June 3pm GMT You can find the zoom details and the link to our previous webinar below: ucl.ac.uk/tb/access-rifa…

bhekisisa.org/health-news-so…

The 3 HP regimen has better completion rates, lower hepatotoxicity than 6H/9H for LTBI, but systemic drug reactions can occur with low BMI as a risk.I argue for a relook at the uniform 900 mg INH dose in populations with undernutrition, need for pyridoxine, & to document AEs.

New modeling shows the potential impact of #tuberculosis #vaccines M72/AS01E and BCG-revaccination in #India. M72/AS01E could avert 16% cases in Delhi and BCG-revaccination 8.8% Read more bit.ly/4bPCXAd

Sequencing works wonderfully, but can we make it more affordable for clinical care?? "Targeted NGS is highly sensitive and specific for detecting drug resistance across panels of tuberculosis drugs and can be performed directly on clinical samples" thelancet.com/journals/lanin…

#HappeningNow! Second High-Level Meeting of #TB Vaccine Accelerator Council. We are discussing 3 key acceleration tracks: 🟢Accelerate diversification of TB vaccine portfolio 🟢Accelerate identification of market solutions 🟢Accelerate rapid implementation&uptake of TB vaccines

Fantastic news that new vaccines for #TB will be included in GAVI's future portfolio. Huge credit to Dr Marta Tufet Bayona , her team and Gavi, the Vaccine Alliance ! Glad to support Allison Portnoy Rebecca Clark Nick Menzies and all London School of Hygiene & Tropical Medicine CMMID LSHTM TB Centre Vaccine Centre rb.gy/dm4pk8

📢 Free R training material📢 I am making materials for all my courses available for free because I believe science should not be behind a paywall. Free materials are now available for the Intro to R with tidyverse course via bit.ly/4d514vC #rstats #openscience

I encourage young people who are eligible and have a keen interest to apply and serve #globalhealth. #Youth, you are not just our future you are our present too! The Global Fund United Nations Foundation United to Beat Malaria Shot@Life theglobalfund.org/en/updates/202…

Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies - The Lancet Respiratory Medicine thelancet.com/journals/lanre…

A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of drug-resistant tuberculosis (DR-TB). Includes new 6-month & group of 9-month regimens: who.int/publications/i…